Pathstone Family Office’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	$369K	Buy	+1,635	New	+$369K	﹤0.01%	1192
2023 Q1	–	Sell	-2,958	Closed	-$650K	–	1495
2022 Q4	$650K	Buy	2,958 +1,480	+100%	+$325K	0.01%	980
2022 Q3	$309K	Buy	+1,478	New	+$309K	﹤0.01%	1211